BTA
Click for more information
0.00% 57.0¢ biota holdings limited

players in the rhinovirus space

  1. cgt2009
    13,916 Posts.
    lightbulb Created with Sketch. 124
    clock Created with Sketch.
    19/06/13
    19:46
    Post #: 11904784
    During my monthly ritual of googling all things rhinovirus or Vapendavir I came across this Poster released by Gilead Science earlier this year.

    They are screening for anti HRV compounds so they're about 5-6 years behind Vapendavir.

    it's heartening to see BIG players having a dabble in this space....

    Gilead Science Poster on HRV
    BTA Price at posting: 0.0¢ Sentiment: Hold Disclosure: Held
    Likes Created with Sketch.  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

SFX Sheffield Resources achieves milestone production, shipments at Thunderbird, WA
right-arrow Created with Sketch.
TBN Tamboran is developing the NT Beetaloo Basin. To get there, it's listing at $36/sh on the NYSE
right-arrow Created with Sketch.
LYC Lynas eyes first dysprosium, terbium HREE production in CY25
right-arrow Created with Sketch.
SUN ANZ deal to buy Suncorp to go ahead following approval from Treasurer
right-arrow Created with Sketch.
RMS Ramelius boosts WA gold portfolio with stake in Spartan
right-arrow Created with Sketch.
NEWS Microcap Wrap: 5 explorers with news out today
right-arrow Created with Sketch.
watchlist Created with Sketch. Add BTA (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.